Literature DB >> 33561577

Quantitative proteomics and phosphoproteomics of Trypanosoma cruzi epimastigote cell cycle.

Agenor de Castro Moreira Dos Santos Júnior1, Reynaldo Magalhães Melo2, Bianca Vasconcelos Gomes Ferreira3, Arthur Henriques Pontes2, Consuelo Medeiros Rodrigues de Lima2, Wagner Fontes2, Marcelo Valle de Sousa2, Beatriz Dolabela de Lima3, Carlos André Ornelas Ricart4.   

Abstract

The protozoan Trypanosoma cruzi is the causative agent of the neglected infectious illness Chagas disease. During its life cycle it differentiates into replicative and non-replicative life stages. So far, T. cruzi cell division has been investigated by transcriptomics but not by proteomics approaches. Here we show the first quantitative proteome analysis of T. cruzi cell division. T. cruzi epimastigote cultures were subject to synchronization with hydroxyurea and harvested at different time points. Analysis by flow cytometry, bright field and fluorescence microscopy indicated that samples collected at 0 h, 2 h, 6 h and 14 h overrepresented G1, G1-S, S and M cell cycle phases, respectively. After trypsin digestion of these samples, the resulting peptides were labelled with iTRAQ and subjected to LC-MS/MS. Also, iTRAQ-labelled phosphopeptides were enriched with TiO2 to access the phosphoproteome. Overall, 597 protein groups and 94 phosphopeptides presented regulation with the most remarkable variation in abundance at 6 h (S-phase). Comparison of our proteomic data to previous transcriptome-wise analysis of epimastigote cell cycle showed 16 sequence entries in common, with the highest mRNA/protein correlation observed in transcripts with peak abundance in G1-phase. Our data revealed regulated proteins and phosphopeptides which play important roles in the control of cell division in other organisms and some of them were previously detected in the nucleus or associated with T. cruzi chromatin.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chagas disease; Mitosis; Phosphoproteome; Proteome; Trypanosomatid

Year:  2021        PMID: 33561577     DOI: 10.1016/j.bbapap.2021.140619

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  3 in total

1.  Drug Target Validation of the Protein Kinase AEK1, Essential for Proliferation, Host Cell Invasion, and Intracellular Replication of the Human Pathogen Trypanosoma cruzi.

Authors:  Miguel A Chiurillo; Bryan C Jensen; Roberto Docampo
Journal:  Microbiol Spectr       Date:  2021-09-29

2.  Extensive Translational Regulation through the Proliferative Transition of Trypanosoma cruzi Revealed by Multi-Omics.

Authors:  Santiago Chávez; Michael D Urbaniak; Corinna Benz; Pablo Smircich; Beatriz Garat; José R Sotelo-Silveira; María Ana Duhagon
Journal:  mSphere       Date:  2021-09-01       Impact factor: 4.389

3.  Ablation of the P21 Gene of Trypanosoma cruzi Provides Evidence of P21 as a Mediator in the Control of Epimastigote and Intracellular Amastigote Replication.

Authors:  Thaise Lara Teixeira; Miguel Angel Chiurillo; Noelia Lander; Cassiano Costa Rodrigues; Thiago Souza Onofre; Éden Ramalho Ferreira; Camila Miyagui Yonamine; Júlia de Gouveia Santos; Renato Arruda Mortara; Claudio Vieira da Silva; José Franco da Silveira
Journal:  Front Cell Infect Microbiol       Date:  2022-02-18       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.